SCHEMBL14119232

SCHEMBL14119232

BrCc1ccc(-c2nc3ccccc3nc2-c2ccccc2)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.58
L3MBTL1 Q9Y468 6/20 0.58
LMNA P02545 4/20 0.58
GAA P10253 3/20 0.58
TDP1 Q9NUW8 2/20 0.58
KMT2A Q03164 2/20 0.58
MEN1 O00255 1/20 0.58
ALDH1A1 P00352 7/20 0.53
NPSR1 Q6W5P4 1/20 0.53
PKM P14618 1/20 0.50
AKT1 P31749 1/20 0.50
AKT2 P31751 1/20 0.50
TRPA1 O75762 1/20 0.48
TSHR P16473 1/20 0.48
THRB P10828 1/20 0.47
ERBB2 P04626 1/20 0.47
ATM Q13315 1/20 0.46
TLR9 Q9NR96 1/20 0.46
MAPK10 P53779 1/20 0.44
MAPK14 Q16539 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6152409 0.85 ALDH1A1 (0.56) KDM4EL3MBTL1LMNAGAATDP1
SCHEMBL13950894 0.83 KDM4E (0.78) KDM4EL3MBTL1LMNAGAATDP1
SCHEMBL22769174 0.81 KDM4E (0.75) KDM4EL3MBTL1LMNAGAATDP1
SCHEMBL22769176 0.81 KDM4E (0.75) KDM4EL3MBTL1LMNAGAATDP1
SCHEMBL13726198 0.81 KDM4E (0.75) KDM4EL3MBTL1LMNAGAATDP1
SCHEMBL24590007 0.81 KDM4E (0.75) KDM4EL3MBTL1LMNAGAATDP1
SCHEMBL732131 0.81 KDM4E (0.74) KDM4EL3MBTL1LMNAGAATDP1
SCHEMBL29382173 0.81 KDM4E (0.74) KDM4EL3MBTL1LMNAGAATDP1
SCHEMBL14119243 0.81 TAAR1 (0.63) KDM4EL3MBTL1LMNAGAATDP1
SCHEMBL16981100 0.81 KMT2A (0.63) KDM4EL3MBTL1LMNAGAATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7396832-B2 Inhibitors of Akt activity MERCK & CO., INC. (US) 2008-07-08 US disclosed
US-7396832-B2 Inhibitors of Akt activity MERCK & CO., INC. (US) 2008-07-08 US disclosed
US-20070149536-A1 Inhibitors of Akt activity MERCK SHARP & DOHME CORP. 2007-06-28 US disclosed
US-20070149536-A1 Inhibitors of Akt activity MERCK SHARP & DOHME CORP. 2007-06-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070149536-A1 Inhibitors of Akt activity AKT1, AKT2, AKT3 KDM4E 1347/4885L3MBTL1 2879/4885LMNA 4297/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.